Cost-effectiveness Analysis of 99mTc-sestamibi SPECT/CT to Guide Management of Small Renal Masses-Reference-Cited by-同舟云学术

Cost-effectiveness Analysis of 99mTc-sestamibi SPECT/CT to Guide Management of Small Renal Masses

Published:2021-07 Issue:4 Volume:7 Page:827-834
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Su Zhuo T.^ORCID,Patel Hiten D.^ORCID,Huang Mitchell M.^ORCID,Meyer Alexa R.,Pavlovich Christian P.^ORCID,Pierorazio Phillip M.,Javadi Mehrbod S.,Allaf Mohamad E.,Rowe Steven P.,Gorin Michael A.

Funder

School of Medicine, Johns Hopkins University

Publisher

Elsevier BV

Subject

Urology

Reference24 articles.

1. Clinical stage migration and survival for renal cell carcinoma in the United States;Patel;Eur Urol Oncol,2019

2. The probability of aggressive versus indolent histology based on renal tumor size: implications for surveillance and treatment;Bhindi;Eur Urol,2018

3. Surgical removal of renal tumors with low metastatic potential based on clinical radiographic size: a systematic review of the literature;Patel;Urol Oncol Semin Orig Investig,2019

4. Renal mass and localized renal cancer: AUA guideline;Campbell;J Urol,2017

5. European Association of Urology guidelines on renal cell carcinoma: the 2019 update;Ljungberg;Eur Urol,2019

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of 99mTc‐Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta‐analysis;European Urology;2024-01

2. Reply to Giovanni Lughezzani, Paolo Casale, and Laura Evangelista’s Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.07.013;European Urology;2023-12

3. Insights into Renal Cell Carcinoma with Novel Imaging Approaches;Hematology/Oncology Clinics of North America;2023-10

4. Clinical Performance of Technetium-99m–Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors From Renal Cell Carcinoma in Routine Clinical Practice;Journal of Urology;2023-09

5. Machine Learning Integrating 99mTc Sestamibi SPECT/CT and Radiomics Data Achieves Optimal Characterization of Renal Oncocytic Tumors;Cancers;2023-07-09